Clinical Trial

Trial for Reliability of Urodynamics SysTem

Study acronym: TRUST-1
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 30, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this prospective trial is to assess the safety and reliability of the Glean Urodynamics System (GUS) in adult females with lower urinary tract symptoms. The main question\[s\] it aims to answer are: • What is GUS's ability to safely and reliably conduct wireless, catheter-free monitoring of vesical pressure compared to the vesical pressures collected with conventional urodynamics? Participants will undergo a conventional urodynamics exam, a simultaneous urodynamics exam with GUS, ambulatory urodynamics with GUS, and extended home monitoring with GUS. Researchers will compare GUS data with that from a conventional urodynamics exam.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-01
Trial Details
NCT Number NCT05694793
Lead Sponsor Bright Uro
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions Urologic Diseases, Urodynamics
Enrollment 28 participants
Start Date 2025-06-03
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-06-30